ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,420Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 1692

$1.47M Total Retail Price of All Prescriptions

Rank: 12 out of 1692

825 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 825 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

24% of this provider’s 825 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 17,176 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
HYDROCODONE-ACETAMINOPHEN 1,323 726 S3 1 6
FUROSEMIDE 911 602 2 7
OMEPRAZOLE 790 468 3 5
AMLODIPINE BESYLATE 733 533 4 3
METOPROLOL TARTRATE 689 475 5 10
PRAVASTATIN SODIUM 686 492 6 12
LISINOPRIL 672 395 7 2
GABAPENTIN 648 343 8 13
LEVOTHYROXINE SODIUM 611 470 9 4
WARFARIN SODIUM 551 347 10 14
SIMVASTATIN 511 347 11 1
LISINOPRIL-HYDROCHLOROTHIAZIDE 474 332 12 19
OXYCODONE HCL 408 67 S2 13 56
CITALOPRAM HBR 376 205 14 21
TRAMADOL HCL 370 266 15 16
METFORMIN HCL 316 189 16 8
POTASSIUM CHLORIDE 315 237 17 20
GLIPIZIDE 300 199 18 47
RANITIDINE HCL 271 148 19 28
HYDROCHLOROTHIAZIDE 252 173 20 9
ISOSORBIDE MONONITRATE ER 244 227 21 55
DICLOFENAC SODIUM 243 153 22 75
ALLOPURINOL 235 202 23 30
CARVEDILOL 234 179 24 24
NEXIUM 232 113 25 25
SPIRIVA 223 131 26 44
SERTRALINE HCL 221 100 27 22
PROAIR HFA 220 100 28 40
PAROXETINE HCL 214 139 29 60
TRAZODONE HCL 207 70 30 33
CLONIDINE HCL 201 127 31 46
METFORMIN HCL ER 196 108 32 49
CLOPIDOGREL 192 169 33 43
MIRTAZAPINE 191 146 34 53
METOPROLOL SUCCINATE 190 145 35 18
JANUVIA 186 118 36 72
DOXEPIN HCL 177 61 37 204
KLOR-CON M10 176 134 38 106
ADVAIR DISKUS 171 58 39 45
LACTULOSE 170 97 40 104
PROMETHAZINE HCL 169 59 R 41 81
AMITRIPTYLINE HCL 167 80 R 42 58
TAMSULOSIN HCL 166 139 43 31
FLUTICASONE PROPIONATE 164 91 44 27
FENTANYL 164 64 S2 44 88
HYDRALAZINE HCL 158 137 46 92
OXYCODONE-ACETAMINOPHEN 154 80 S2 47 70
ATORVASTATIN CALCIUM 153 101 48 11
ZOLPIDEM TARTRATE 151 88 49 23
ATENOLOL 150 120 50 15
QUETIAPINE FUMARATE 150 104 50 62
POLYETHYLENE GLYCOL 3350 147 103 52 64
BACLOFEN 145 87 53 115
DIGOXIN 144 130 54 85
CYCLOBENZAPRINE HCL 142 31 R 55 54
PLAVIX 140 124 56 66
KLOR-CON M20 137 95 57 48
METHADONE HCL 131 0 S2 58 135
METOCLOPRAMIDE HCL 130 42 59 146
LOSARTAN POTASSIUM 121 118 60 17
IBUPROFEN 121 56 60 78
AZITHROMYCIN 119 72 62 34
PREDNISONE 118 66 63 35
ESCITALOPRAM OXALATE 113 80 64 76
LOVASTATIN 111 85 65 37
ALENDRONATE SODIUM 110 97 66 36
LANTUS SOLOSTAR 110 64 66 102
NAMENDA 108 100 68 50
CARBIDOPA-LEVODOPA 107 96 69 110
CYMBALTA 104 28 70 51
DONEPEZIL HCL 103 92 71 29
TRIAMCINOLONE ACETONIDE 102 58 72 105
GLIPIZIDE ER 101 69 73 87
DIOVAN 99 99 74 42
RISPERIDONE 98 53 75 77
SPIRONOLACTONE 98 44 75 74
MORPHINE SULFATE ER 94 28 S2 77 121
GEMFIBROZIL 94 33 77 98
BUPROPION HCL SR 93 14 79 171
OXYBUTYNIN CHLORIDE 91 71 80 162
LANTUS 91 71 80 57
PHENYTOIN SODIUM EXTENDED 88 55 82 136
PEN NEEDLE 87 60 83 168
OXYCONTIN 87 0 S2 83 148
THEOPHYLLINE ANHYDROUS 87 46 83 210
PRAMIPEXOLE DIHYDROCHLORIDE 85 58 86 216
CRESTOR 83 76 87 26
SULINDAC 82 52 88 303
OXYCODONE HCL-ACETAMINOPHEN 79 28 S2 89 94
DOXYCYCLINE HYCLATE 79 44 89 126
PANTOPRAZOLE SODIUM 78 51 91 39
CHLORZOXAZONE 78 56 R 91 367
AZELASTINE HCL 77 43 93 272
NITROSTAT 77 62 93 225
TRICOR 76 56 95 112
DIOVAN HCT 76 53 95 73
SEROQUEL 76 60 95 130
AMLODIPINE BESYLATE-BENAZEPRIL 75 65 98 67
DILTIAZEM 24HR ER 75 63 98 134
VENLAFAXINE HCL ER 73 11 100 84
NIASPAN 71 58 101 123
NAPROXEN 70 38 102 91
FINASTERIDE 70 65 102 99
SINGULAIR 69 22 104 79
ESTRADIOL 63 16 R 105 227
BUSPIRONE HCL 62 30 106 122
TOPIRAMATE 60 0 107 164
GLYBURIDE-METFORMIN HCL 59 55 R 108 157
HYDROMORPHONE HCL 58 0 S2 109 192
ISOSORBIDE DINITRATE 58 50 109 268
INSULIN SYRINGE 57 45 111 93
NOVOLOG FLEXPEN 55 50 112 169
AMIODARONE HCL 55 43 112 234
EVISTA 55 54 112 140
LEVEMIR FLEXPEN 52 33 115 149
VENTOLIN HFA 52 20 115 151
LEVEMIR 51 27 117 184
NOVOLOG 51 30 117 120
DIVALPROEX SODIUM 50 33 119 97
GLYBURIDE 50 43 R 119 82
DILTIAZEM HCL 50 46 119 244
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 12, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.